Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies.
Fofana I, Fafi-Kremer S, Carolla P, Fauvelle C, Zahid MN, Turek M, Heydmann L, Cury K, Hayer J, Combet C, Cosset FL, Pietschmann T, Hiet MS, Bartenschlager R, Habersetzer F, Doffoël M, Keck ZY, Foung SKH, Zeisel MB, Stoll-Keller F, Baumert TF. Fofana I, et al. Among authors: doffoel m. Gastroenterology. 2012 Jul;143(1):223-233.e9. doi: 10.1053/j.gastro.2012.04.006. Epub 2012 Apr 10. Gastroenterology. 2012. PMID: 22503792 Free PMC article.
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation.
Fafi-Kremer S, Fofana I, Soulier E, Carolla P, Meuleman P, Leroux-Roels G, Patel AH, Cosset FL, Pessaux P, Doffoël M, Wolf P, Stoll-Keller F, Baumert TF. Fafi-Kremer S, et al. Among authors: doffoel m. J Exp Med. 2010 Aug 30;207(9):2019-31. doi: 10.1084/jem.20090766. Epub 2010 Aug 16. J Exp Med. 2010. PMID: 20713596 Free PMC article.
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.
Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, Zona L, Davis C, Mee CJ, Turek M, Gorke S, Royer C, Fischer B, Zahid MN, Lavillette D, Fresquet J, Cosset FL, Rothenberg SM, Pietschmann T, Patel AH, Pessaux P, Doffoël M, Raffelsberger W, Poch O, McKeating JA, Brino L, Baumert TF. Lupberger J, et al. Among authors: doffoel m. Nat Med. 2011 May;17(5):589-95. doi: 10.1038/nm.2341. Epub 2011 Apr 24. Nat Med. 2011. PMID: 21516087 Free PMC article.
Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.
Schvoerer E, Moenne-Loccoz R, Murray JM, Velay A, Turek M, Fofana I, Fafi-Kremer S, Erba AC, Habersetzer F, Doffoël M, Gut JP, Donlin MJ, Tavis JE, Zeisel MB, Stoll-Keller F, Baumert TF. Schvoerer E, et al. Among authors: doffoel m. J Infect Dis. 2013 Apr 15;207(8):1306-15. doi: 10.1093/infdis/jit032. Epub 2013 Jan 18. J Infect Dis. 2013. PMID: 23335805
Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection.
Habersetzer F, Leboeuf C, Doffoël M, Zeisel MB, Baumert TF. Habersetzer F, et al. Among authors: doffoel m. Expert Opin Investig Drugs. 2013 Jul;22(7):853-62. doi: 10.1517/13543784.2013.794218. Epub 2013 May 2. Expert Opin Investig Drugs. 2013. PMID: 23634817 Review.
Neutralizing antibodies in hepatitis C virus infection.
Zeisel MB, Fafi-Kremer S, Fofana I, Barth H, Stoll-Keller F, Doffoel M, Baumert TF. Zeisel MB, et al. Among authors: doffoel m. World J Gastroenterol. 2007 Sep 28;13(36):4824-30. doi: 10.3748/wjg.v13.i36.4824. World J Gastroenterol. 2007. PMID: 17828813 Free PMC article. Review.
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.
Zeisel MB, Koutsoudakis G, Schnober EK, Haberstroh A, Blum HE, Cosset FL, Wakita T, Jaeck D, Doffoel M, Royer C, Soulier E, Schvoerer E, Schuster C, Stoll-Keller F, Bartenschlager R, Pietschmann T, Barth H, Baumert TF. Zeisel MB, et al. Among authors: doffoel m. Hepatology. 2007 Dec;46(6):1722-31. doi: 10.1002/hep.21994. Hepatology. 2007. PMID: 18000990 Free article.
Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.
Haberstroh A, Schnober EK, Zeisel MB, Carolla P, Barth H, Blum HE, Cosset FL, Koutsoudakis G, Bartenschlager R, Union A, Depla E, Owsianka A, Patel AH, Schuster C, Stoll-Keller F, Doffoël M, Dreux M, Baumert TF. Haberstroh A, et al. Among authors: doffoel m. Gastroenterology. 2008 Nov;135(5):1719-1728.e1. doi: 10.1053/j.gastro.2008.07.018. Epub 2008 Jul 22. Gastroenterology. 2008. PMID: 18718838
[Neutralizing antibodies in hepatitis C virus infection].
Fafi-Kremer S, Zeisel MB, Schvoerer E, Soulier E, Habersetzer F, Wolf P, Doffoel M, Baumert TF, Stoll-Keller F. Fafi-Kremer S, et al. Among authors: doffoel m. Gastroenterol Clin Biol. 2008 May;32(5 Pt 1):491-8. doi: 10.1016/j.gcb.2008.02.026. Epub 2008 May 7. Gastroenterol Clin Biol. 2008. PMID: 18467058 Free article. Review. French.
176 results